Mrs. Ankita Singal Appointed as Non-Executive Independent Women Director at Modi Biotech Private Limited
Modi Naturals Limited, through its subsidiary Modi Biotech Private Limited, announced the appointment of Mrs. Ankita Singal as a Non-Executive Independent Women Director. The appointment was approved by the Members of Modi Biotech Private Limited during their 5th Annual General Meeting held on July 30, 2026.Mrs. Ankita Singal holds the position effective from July 30, 2026. She is described as having approximately 20 years of experience in finance, marketing, and general business management. Her educational qualifications include a B.Com (H) from Lady Sriram College for Women, Delhi University, and a Master's degree in Business Administration from Infinity Business School.
The appointment structure confirms that Mrs. Singal is not related to any Directors of the Company. Furthermore, it was stated that she is not debarred from holding the office of Director by virtue of any MCA or SEBI order or order of any other such Authorities.
Key details regarding the director and her appointment are summarized below:
| Attribute | Detail |
|---|---|
| Director's Name | Mrs. Ankita Singal (DIN: 01633449) |
| Role | Non-Executive Independent Women Director |
| Company | Modi Biotech Private Limited |
| Date of Appointment | July 30, 2026 |
| Experience Profile | Approximately 20 years in finance, marketing, and general business management. |
| Relatedness | Not related to any Directors of the Company. |
MODINATUR Stock Price Movement
Modi Naturals Limited shares slipped today to settle at ₹397.30, shedding 1.5% in post-market trading. The stock saw a reported volume of 2,296 shares as the company concluded its day on the exchange.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.